Surfactants

Abstract Poor aqueous solubility limits the in vitro dissolution performance of many drugs, among them curcumin which is a bioactive...

Abstract Background: Lipid nanoparticles are widely investigated as oral drug delivery systems, but their intestinal performance remains difficult to predict based...

Lipid-based excipients from IOI Oleo help to improve the bioavailability of poorly soluble active ingredients. The majority of new active...

Abstract Transdermal drug delivery offers several advantages over conventional routes. However, its use is limited by the low permeability of...

Biopharmaceutical excipients are the inactive substances added to biologic drug products to protect large, structurally fragile biomolecules, such as monoclonal...

Article by David Tisi, Senopsys LLC: The principle of dual sourcing excipients is well established in pharmaceutical development, and its importance...

Abstract Carbohydrate-based polymers are increasingly recognized as sustainable materials for additive manufacturing. For the first time, Starch 1500®, a partially...

Abstract Background: Rebamipide (REB) is a poorly water-soluble drug with limited ocular bioavailability, necessitating advanced delivery strategies for sustained therapy in...

Abstract Background: Inflammation is a complex biological response associated with various pathological conditions, necessitating the development of effective and safer...

Abstract Hydroxypropyl methylcellulose acetate succinate (HPMCAS) is commonly used to develop amorphous solid dispersions (ASDs), but its use is mostly...